Edwards Lifesciences
1,017 hedge funds and large institutions have $32.1B invested in Edwards Lifesciences in 2020 Q1 according to their latest regulatory filings, with 105 funds opening new positions, 352 increasing their positions, 407 reducing their positions, and 166 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
20% less capital invested
Capital invested by funds: $40.3B → $32.1B (-$8.17B)
28% less funds holding in top 10
Funds holding in top 10: 29 → 21 (-8)
37% less first-time investments, than exits
New positions opened: 105 | Existing positions closed: 166
Holders
1,017
Holding in Top 10
21
Calls
$169M
Puts
$121M
Top Buyers
| 1 | +$366M | |
| 2 | +$254M | |
| 3 | +$155M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$133M |
| 5 |
CG
Carmignac Gestion
Paris,
France
|
+$93.8M |
Top Sellers
| 1 | -$702M | |
| 2 | -$344M | |
| 3 | -$313M | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$160M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$148M |